While the world deals with the impacts of COVID-19, Avricore Health has utilized its network of suppliers and customers and Health Canada Licences to drive interim revenues.  VANCOUVER, British Columbia, June 29, 2020 — Avricore Health (TSXV: AVCR) like so many other business, has faced both challenges and opportunities over

HealthTab was used to study at-risk patients in the community pharmacy setting, demonstrating the effectiveness of point-of-care testing to better screen, treat and follow up with serious chronic illness The team at Avricore Health (TSXV: AVCR) is very pleased to have the first study published utilizing its revolutionary integrated point-of-care

VANCOUVER, British Columbia, March 6, 2020 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company“) a leader in point-ofcare testing and health data generation, announced today that subject to regulatory approval it has entered into a loan agreement with Canam Online Ltd. for a

VANCOUVER, British Columbia, Nov. 28, 2019 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce it will be placing HealthTab™ systems in 11 new community pharmacy locations more than doubling the number of HealthTab™ systems located in community pharmacies. “We are focused

VANCOUVER, BC – (GLOBE NEWSWIRE) – November 18, 2019 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are pleased to announce a Memorandum of Understanding (MOU) to offer in partnership the Company’s HealthTab point-of-care blood screening system to OPA

VANCOUVER – (GLOBE NEWSWIRE) – October 15, 2019 – Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) Board of Directors announces the appointment of Hector Bremner as Chief Executive Officer and Bob Rai as President effective immediately. Bremner previously held the position of Executive Vice President

VANCOUVER, British Columbia, Sept. 17, 2019 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce that it has signed a first stage agreement in the form of a Letter of Intent (LOI) with Dubai based clinical research organization, Clinart, to

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Aug. 20, 2019 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to provide an update on the significant progress the company has made over the summer

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES  VANCOUVER, British Columbia, Aug. 13, 2019 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company“) announces that it has closed the first tranche of its previously announced non-brokered private placement by issuing

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES  VANCOUVER, British Columbia, Aug. 06, 2019 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) announces the appointment of Ms. Kiki Smith, CPA, CGA to the role of Chief Financial Officer, where